Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Charles River Laboratories
Fierce Biotech
Charles River sells CDMO and discovery assets in strategic pivot
The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.
Darren Incorvaia
Feb 25, 2026 1:54pm
Fierce Biotech
Charles River to close Maryland CDMO site, lay off 20 staffers
Feb 3, 2026 12:20pm
Charles River to help Navega produce gene therapy candidate
Mar 14, 2024 9:50am
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Charles River Labs looks to keep growing with evolving industry
Jun 13, 2023 7:43am
China's reimbursement talks, Sun, GenScript—Fierce Pharma Asia
Jan 20, 2023 9:00am
